Related Experiment Video

Updated: Apr 4, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

23.7K

[Comorbidity of depressive disorders and coronary heart disease: general aspects of pathogenesis]

N G Neznanov1, S N Kozlova2, G E Mazo3

  • 1Bekhterev St. Petersburg Research Psychoneurological Institute, St. Petersburg; Pavlov First State Medical University, St. Petersburg.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|September 11, 2015
PubMed

Insights

Coronary heart disease (CHD) patients with depression show higher pro-inflammatory markers (IL-6, TNF-α) and LDL cholesterol. Platelet serotonin levels correlate with higher cholesterol in these patients.

Area of Science:

  • Cardiovascular Medicine
  • Psychiatry
  • Biochemistry

Context:

  • Comorbidity of coronary heart disease (CHD) and depressive disorders presents a significant clinical challenge.
  • Understanding the shared pathogenesis is crucial for effective treatment strategies.

Purpose:

  • To investigate the relationship between depressive disorders and specific biomarkers in patients with coronary heart disease (CHD).
  • To analyze cholesterol levels, platelet serotonin, platelet aggregation, and pro-inflammatory markers in CHD patients with comorbid depression.

Summary:

  • Depressive disorders in CHD patients are linked to elevated pro-inflammatory markers (IL-6, TNF-α) and high-density lipoproteins (LDL).
  • Higher platelet serotonin levels in comorbid patients correlate with increased cholesterol.
  • No significant differences in platelet function were observed between CHD patients with and without depression.

Impact:

  • Findings highlight the inflammatory link between depression and CHD, suggesting potential therapeutic targets.
  • Identifies platelet serotonin as a potential indicator of cholesterol levels in this patient group.
  • Informs clinical practice regarding the management of comorbid CHD and depression.
Abstract

More Related Videos

A New Method for Inducing a Depression-Like Behavior in Rats07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

22.6K

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.1K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
573
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
863
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
674
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
992